leadf
logo-loader
AIM:NSCI

Netscientific PLC

Receive alerts
Market:
AIM
Market Cap:
£8.43 m
Price
56.50 GBX
Change
-0.88%
52 weeks high
200.00
52 weeks low
9.75

In brief

A Transatlantic healthcare technology group

Through our US-UK network, we source, develop and manage early/mid-stage healthcare technology companies focused on Diagnostics, Digital health and Therapeutics.

We are focused on providing management support for our investments which can involve senior team members at NetScientific taking leadership roles in portfolio companies, in the early stages of investment, to build out dedicated management teams.

Snapshot

  • Three portfolio companies: Glycotest, PDS Biotech and ProAxsis

  • £2.5mln of cash in the bank

  • PDS Biotech due to carry out phase II trial of lead drug this year